| 5/13/2019 | BK | Market Commentary: Wheel Pros, FirstLight free up; PCI Gaming revises deadline; Vertafore, Hudson set talk
|
| 5/13/2019 | BK | Royalty Pharma withdraws $800 million term loan B from market
|
| 5/3/2019 | BK | S&P gives BBB- to Royalty Pharma loan
|
| 4/30/2019 | BK | Market Commentary: Process Solutions, Flexera break; ION tweaked; Charter NEX, Radiology Partners accelerated
|
| 4/30/2019 | BK | Royalty Pharma talks $800 million term loan B at Libor plus 225 bps
|
| 4/29/2019 | BK | Market Commentary: Kestra, NVA, Livingston, Sound Physicians free to trade; Flexera moves commitment deadline
|
| 4/29/2019 | BK | Royalty Pharma to launch $800 million term loan B on Tuesday
|
| 4/19/2017 | BKIG | S&P gives BBB- to RPI Finance loan
|
| 3/16/2017 | BK | Market Commentary: GEO, RPI, Summit, Eldorado, Navex break; Lumileds, Avast, Lightstone, Foresight revised
|
| 4/24/2015 | BK | Royalty Pharma set to launch $1 billion add-on term loan B-4 on Monday
|
| 12/11/2014 | BK | Market Commentary: Compuware, RentPath, Royalty Pharma, Sage Products, Distribution International break
|
| 12/10/2014 | BK | Market Commentary: Creative Artists, Varsity Brands break; Sage, Royalty Pharma, Siemens Audiology update deals
|
| 12/10/2014 | BK | Royalty Pharma trims term loan B-4 to $700 million, lowers pricing
|
| 12/2/2014 | BK | S&P applies BBB- to Royalty Pharma loans
|
| 12/1/2014 | BK | Market Commentary: TierPoint breaks; Royalty Pharma guidance surfaces; primary calendar continues to build
|
| 12/1/2014 | BK | Royalty Pharma launches $1.5 billion term B-4 at Libor plus 300-325 bps, OID of 99½
|
| 11/25/2014 | BK | Market Commentary: Tibco, Tecomet, Global Cash, Packers, Equinox, ION break; Unite Private, Terra-Gen revised
|
| 11/25/2014 | BK | Royalty Pharma to launch $1.5 billion term loan B-4 on Monday
|
| 11/19/2014 | BK | Royalty Pharma uses $2.7 billion term loan for royalties acquisition
|
| 2/25/2013 | BK | Royalty Pharma expects to use new debt financing for Elan buyout bid
|
| 7/16/2012 | BK | Fitch affirms RP Select
|
| 5/24/2012 | BK | Market Commentary: Misys, Royalty Pharma, Roofing break; Wolverine, Hearthside, AlixPartners revise deals
|
| 5/24/2012 | BK | Royalty Pharma increases add-on term loan size to $600 million
|
| 5/23/2012 | BK | Royalty Pharma widens discount on $500 million add-on term loan to 981/2
|
| 5/23/2012 | BK | Market Commentary: SS&C, Granite, CAMP, AmWINS break; Royalty Pharma, Roofing, EVO, Rivers revise deals
|
| 5/17/2012 | BK | Market Commentary: Momentive, U.S. Foodservice lower; Misys revises deadline; Lord & Taylor cancels repricing
|
| 5/17/2012 | BK | Royalty Pharma launches $500 million add-on term loan at OID of 99-991/2
|
| 5/15/2012 | BK | Royalty Pharma add-on term loan due 2018 sized at $500 million
|
| 5/14/2012 | BK | Royalty Pharma readies launch of add-on loan due 2018 for Thursday
|
| 5/14/2012 | BK | Market Commentary: Arch Coal frees up; Bausch & Lomb launches delayed-draw syndication; Jazz reveals timing
|
| 5/3/2012 | BK | Moody's: Royalty Pharma stable
|
| 8/1/2011 | BK | Market Commentary: Royalty Pharma, Stackpole break; Nursing home sector retreats as Medicare cuts payments
|
| 8/1/2011 | BK | Royalty Pharma firms tranching on $2.75 billion of institutional debt
|
| 7/14/2011 | BK | Royalty Pharma reveals price talk on $3.6 billion credit facility
|
| 7/14/2011 | BK | Market Commentary: El Pollo breaks; Cumulus, Evans, Vertafore tweak deals; Autoparts accelerates deadline
|
| 7/12/2011 | BK | Market Commentary: Primedia, inVentiv, Ashland break; Reynolds, Dynegy, Stackpole, U.S. Security talk emerges
|
| 7/12/2011 | BK | Royalty Pharma to launch $3.6 billion credit facility on Thursday
|
| 5/9/2008 | BK | S&P rates Royalty Pharma loan BB+
|
| 5/5/2008 | BKHY | Royalty Pharma launches $200 million unsecured seven-year fixed-rate term loan via Banc of America Securities
|
| 3/27/2008 | BKHYIG | S&P ups Royalty Pharma from junk
|
| 12/20/2007 | BK | Market Commentary: Royalty Pharma breaks; Rite Aid down on numbers; Lear up with revised outlook; Superior pulls loan
|
| 12/19/2007 | BK | Market Commentary: Tribune up as going-private closing nears; TravelClick firms spreads; Royalty Pharma readies allocations
|
| 12/6/2007 | BK | Market Commentary: Tribune slides on company performance concerns; Royalty Pharma sets talk, OID; Husky Injection upsizes
|
| 12/6/2007 | BK | Royalty Pharma $700 million term B add-on launches at Libor plus 225 bps, OID 99
|
| 12/5/2007 | BK | Market Commentary: NewPage firms OID; Royalty Pharma floats talk; General Motors inches lower; LCDX up
|
| 12/5/2007 | BK | Royalty Pharma $700 million term B add-on talked at Libor plus 200 bps to 225 bps
|
| 12/4/2007 | BK | S&P affirms Royalty Pharma
|
| 11/27/2007 | BK | Royalty Pharma to launch $700 million term B add-on on Dec. 6
|
| 5/14/2007 | BK | Market Commentary: Aeroflex sets talk; Tribune flexes up; Noranda adds step; Edgen Murray, Royalty Pharma break
|
| 4/24/2007 | BK | S&P gives Royalty Pharma, loan BB+
|
| 4/24/2007 | BK | Royalty Pharma launches $1.4 billion term loan
|
